Literature DB >> 30563918

Novel educational program improves readiness to manage intimate partner violence within the fracture clinic: a pretest-posttest study.

.   

Abstract

BACKGROUND: Intimate partner violence (IPV) is prevalent among female patients at fracture clinics; however, previous research suggests health care providers (HCPs) are unprepared to identify victims and provide appropriate support. To address this gap in care, we developed an IPV educational program and conducted a study to measure the impact of this program on HCPs' IPV-related knowledge, attitudes, beliefs and self-reported behaviours.
METHODS: We enrolled 140 participants (orthopedic surgeons, surgical trainees, nonphysician HCPs and research and administrative staff) from 7 fracture clinics in North America who completed the 2-hour educational program. We used a pretest-posttest study design to assess knowledge, attitudes, beliefs and self-reported behaviours. We administered the Physician Readiness to Manage IPV Survey before, immediately after and 3 months after training and generated scores for each of the 10 subscales. Our primary outcome was change in score for the actual knowledge subscale from before training to 3 months after training. We used linear regression to conduct all analyses.
RESULTS: We found significant improvement on the actual knowledge subscale 3 months after the training (mean difference [MD] 2.44, 95% confidence interval [CI] 1.79 to 3.09). We found statistically significant improvements on 7 additional subscales 3 months after training (perceived preparation [MD 1.96, 95% CI 1.79 to 2.13], perceived knowledge [MD 2.05, 95% CI 1.88 to 2.23], practice issues [MD 6.10, 95% CI 4.98 to 7.23], preparation [MD 1.06, 95% CI 0.89 to 1.22], legal requirements [MD 1.50, 95% CI 1.30 to 1.70], workplace issues [MD 1.11, 95% CI 0.97 to 1.26] and self-efficacy [MD 0.54, 95% CI 0.45 to 0.63]) and on all 10 subscales immediately after training (actual knowledge [MD 3.35, 95% CI 2.77 to 3.94], perceived preparation [MD 2.06, 95% CI 1.88 to 2.23], perceived knowledge [MD 2.14, 95% CI 1.98 to 2.30], practice issues [MD 4.08, 95% CI 3.35 to 4.82], preparation [MD 1.04, 95% CI 0.89 to 1.20], legal requirements [MD 1.66, 95% CI 1.47 to 1.85], workplace issues [MD 1.08, 95% CI 0.96 to 1.20], self-efficacy [MD 0.56, 95% CI 0.49 to 0.63], alcohol/drugs [MD 0.20, 95% CI 0.10 to 0.30] and victim understanding [MD 0.15, 95% CI 0.04 to 0.25]).
INTERPRETATION: Our educational program led to significant improvements in participants' readiness to manage IPV. This finding suggests HCPs are better prepared to help patients who experience IPV; however, future research should aim to investigate the impact of this program directly on patients. Copyright 2018, Joule Inc. or its licensors.

Entities:  

Year:  2018        PMID: 30563918      PMCID: PMC6298867          DOI: 10.9778/cmajo.20180150

Source DB:  PubMed          Journal:  CMAJ Open        ISSN: 2291-0026


  5 in total

1. 

Authors:  Nori L Bradley; Ashley M DiPasquale; Kaitlyn Dillabough; Prism S Schneider
Journal:  CMAJ       Date:  2020-11-09       Impact factor: 8.262

2.  Health care practitioners' responsibility to address intimate partner violence related to the COVID-19 pandemic.

Authors:  Nori L Bradley; Ashley M DiPasquale; Kaitlyn Dillabough; Prism S Schneider
Journal:  CMAJ       Date:  2020-05-01       Impact factor: 8.262

3.  Assessing readiness to manage intimate partner violence 12 months after completion of an educational program in fracture clinics: a pretest-posttest study.

Authors: 
Journal:  CMAJ Open       Date:  2020-11-16

4.  Demographics and Fracture Patterns of Patients Presenting to US Emergency Departments for Intimate Partner Violence.

Authors:  Randall T Loder; Luke Momper
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2020-02-18

Review 5.  The Plastic Surgeon's Role in the COVID-19 Crisis: Regarding Domestic Violence.

Authors:  Olivia Abbate Ford; Bharti Khurana; Indranil Sinha; Matthew J Carty; Dennis Orgill
Journal:  Cureus       Date:  2021-01-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.